What is the current annual EBITDA of COR?

As of today, COR annual EBITDA is $4.98B

What is 1-year change in COR annual EBITDA?

COR annual EBITDA is up +20.06% year-over-year

What is 3-year change in COR annual EBITDA?

COR annual EBITDA is up +44.50% over the past 3 years

How far is COR annual EBITDA from its all-time high?

COR annual EBITDA is currently at its all-time high

How does COR annual EBITDA rank versus sector peers?

COR annual EBITDA is higher than 97.68% of companies in Healthcare sector

When is COR next annual earnings release?

As of today, the next annual earnings release for COR has not been scheduled

What is the current quarterly EBITDA of COR?

As of today, COR quarterly EBITDA is $1.61B

What is COR quarterly EBITDA most recent change?

COR quarterly EBITDA was up +27.28% on March 31, 2026

What is 1-year change in COR quarterly EBITDA?

COR quarterly EBITDA is up +26.10% year-over-year

How far is COR quarterly EBITDA from its all-time high?

COR quarterly EBITDA is currently at its all-time high

How does COR quarterly EBITDA rank versus sector peers?

COR quarterly EBITDA is higher than 97.78% of companies in Healthcare sector

When is COR next earnings release?

The next earnings release for COR is on August 5, 2026

What is the current TTM EBITDA of COR?

As of today, COR TTM EBITDA is $5.23B

What is COR TTM EBITDA most recent change?

COR TTM EBITDA was up +6.80% on March 31, 2026

What is 1-year change in COR TTM EBITDA?

COR TTM EBITDA is up +22.23% year-over-year

How far is COR TTM EBITDA from its all-time high?

COR TTM EBITDA is currently at its all-time high

How does COR TTM EBITDA rank versus sector peers?

COR TTM EBITDA is higher than 97.50% of companies in Healthcare sector

When is COR next earnings release?

The next earnings release for COR is on August 5, 2026

Cencora, Inc. (COR) EBITDA History & Chart Since 1994

Annual EBITDA

$4.98B$832.89M+20.06%

September 30, 2025

Summary

Current Value: As of today, COR annual EBITDA is $4.98B, up +20.06% on September 30, 2025
Historical Performance: COR annual EBITDA is up +44.50% over the past 3 years, up +105.46% over the past 5 years
All-Time High Comparison: COR annual EBITDA is currently at its all-time high
3-Year Low Comparison: COR annual EBITDA is +45.80% above its 3-year low of $3.42B reached on September 30, 2023
Sector Comparison: COR annual EBITDA is higher than 97.68% of companies in Healthcare sector

EBITDA Chart

Performance

COR Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Sep 30, 25	$4.98B	+20.1%	+44.5%	+105.5%	+319.7%
Quarterly EBITDA	Mar 31, 26	$1.61B	+26.1%	+65.2%	+100.0%	+308.4%
TTM EBITDA	Mar 31, 26	$5.23B	+22.2%	+58.3%	+92.7%	+313.1%
Price	May 19, 26	$268.35	-8.3%	+54.8%	+126.0%	+541.5%
PE Ratio	May 19, 26	20.59	-39.4%	-7.6%	–	+18.6%
Annual Revenue	Sep 30, 25	$321.33B	+9.3%	+34.7%	+69.2%	+312.2%
Annual EPS	Sep 30, 25	$7.96	+5.7%	-1.0%	+147.8%	+258.6%
	Sep 30, 25	$3.93B	+29.4%	+43.0%	+94.3%	+261.4%
Annual Net Income	Sep 30, 25	$1.57B	+3.2%	-5.9%	+146.1%	+146.2%

EBITDA Highs

COR Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$4.98B	Sep 30, 25	at high
5Y	$4.98B	Sep 30, 25	at high
All	$4.98B	Sep 30, 25	at high

EBITDA Lows

COR Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$3.42B	Sep 30, 23	+45.8%
5Y	$2.43B	N/A	+105.5%
All	$92.60M	Sep 1, 94	+5283.0%

EBITDA History

Year	Value	Change
2025	$4.98B	+20.1%
2024	$4.15B	+21.4%
2023	$3.42B	-0.9%
2022	$3.45B	+8.5%
2021	$3.18B	+31.1%
2020	$2.43B	+3.0%
2019	$2.36B	+9.5%
2018	$2.15B	-11.9%
2017	$2.44B	+18.1%
2016	$2.07B	+32.8%
2015	$1.56B	+13.4%
2014	$1.37B	+18.9%
2013	$1.15B	-19.0%
2012	$1.43B	+5.5%
2011	$1.35B	+13.8%
2010	$1.19B	+20.1%

Year	Value	Change
2009	$989.16M	+8.0%
2008	$915.90M	+3.3%
2007	$886.29M	+8.0%
2006	$820.98M	+14.7%
2005	$715.71M	-25.3%
2004	$957.56M	-1.5%
2003	$972.00M	+16.0%
2002	$838.00M	+177.2%
2001	$302.27M	+38.9%
2000	$217.67M	+13.8%
1999	$191.27M	+14.9%
1998	$166.45M	+24.3%
1997	$133.94M	+22.4%
1996	$109.47M	+1.4%
1995	$107.95M	+16.6%
1994	$92.60M	-

FAQ

What is the current annual EBITDA of COR?
As of today, COR annual EBITDA is $4.98B
What is 1-year change in COR annual EBITDA?
COR annual EBITDA is up +20.06% year-over-year
What is 3-year change in COR annual EBITDA?
COR annual EBITDA is up +44.50% over the past 3 years
How far is COR annual EBITDA from its all-time high?
COR annual EBITDA is currently at its all-time high
How does COR annual EBITDA rank versus sector peers?
COR annual EBITDA is higher than 97.68% of companies in Healthcare sector
When is COR next annual earnings release?
As of today, the next annual earnings release for COR has not been scheduled

Quarterly EBITDA

$1.61B$345.19M+27.28%

March 31, 2026

Summary

Current Value: As of today, COR quarterly EBITDA is $1.61B, up +27.28% on March 31, 2026
Historical Performance: COR quarterly EBITDA is up +26.10% year-over-year, up +65.21% over the past 3 years
All-Time High Comparison: COR quarterly EBITDA is currently at its all-time high
3-Year Low Comparison: COR quarterly EBITDA is +104.14% above its 3-year low of $789.04M reached on September 1, 2023
Sector Comparison: COR quarterly EBITDA is higher than 97.78% of companies in Healthcare sector

Performance

COR Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Mar 31, 26	$1.61B	+27.3%	+26.1%	+65.2%	+100.0%
Annual EBITDA	Sep 30, 25	$4.98B	–	+20.1%	+44.5%	+105.5%
TTM EBITDA	Mar 31, 26	$5.23B	+6.8%	+22.2%	+58.3%	+92.7%
Price	May 19, 26	$268.35	-25.3%	-8.3%	+54.8%	+126.0%
PE Ratio	May 19, 26	20.59	-52.3%	-39.4%	-7.6%	–
Quarterly Revenue	Mar 31, 26	$78.36B	-8.8%	+3.9%	+23.5%	+59.4%
Quarterly EPS	Mar 31, 26	$8.40	+193.2%	+128.3%	+294.1%	+300.1%
	Mar 31, 26	$1.36B	+35.6%	+34.0%	+85.8%	+93.8%
Quarterly Net Income	Mar 31, 26	$1.63B	+187.8%	+127.1%	+280.5%	+275.5%

Quarterly EBITDA Highs

COR Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.61B	Mar 31, 26	at high
3Y	$1.61B	Mar 31, 26	at high
5Y	$1.61B	Mar 31, 26	at high
All	$1.61B	Mar 31, 26	at high

Quarterly EBITDA Lows

COR Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$1.12B	Sep 30, 25	+44.4%
3Y	$789.04M	Sep 1, 23	+104.1%
5Y	$722.10M	Sep 30, 22	+123.1%
All	$22.60M	Sep 1, 96	+7027.4%

Quarterly EBITDA History

Month	Value	Change
Mar 2026	$1.61B	+27.3%
Dec 2025	$1.27B	+13.4%
Sep 2025	$1.12B	-10.2%
Jun 2025	$1.24B	-2.8%
Mar 2025	$1.28B	+19.2%
Dec 2024	$1.07B	+12.6%
Sep 2024	$951.00M	-3.2%
Jun 2024	$982.30M	-14.3%
Mar 2024	$1.15B	+11.6%
Dec 2023	$1.03B	+30.3%
Sep 2023	$789.04M	-6.4%
Jun 2023	$843.06M	-13.5%
Mar 2023	$975.02M	+21.0%
Dec 2022	$805.92M	+11.6%
Sep 2022	$722.10M	-10.2%
Jun 2022	$803.95M	-22.2%
Mar 2022	$1.03B	+15.9%
Dec 2021	$891.59M	+7.1%
Sep 2021	$832.33M	-25.9%
Jun 2021	$1.12B	+39.4%
Mar 2021	$805.57M	+11.8%
Dec 2020	$720.36M	+14.5%
Sep 2020	$629.30M	+12.2%
Jun 2020	$560.83M	-19.5%
Mar 2020	$696.56M	+29.1%
Dec 2019	$539.36M	+16.8%
Sep 2019	$461.84M	-19.5%
Jun 2019	$573.58M	-24.1%
Mar 2019	$755.29M	+33.8%
Dec 2018	$564.33M	+46.2%
Sep 2018	$385.91M	-32.1%
Jun 2018	$568.07M	-10.9%
Mar 2018	$637.92M	+14.2%
Dec 2017	$558.70M	-9.4%
Sep 2017	$616.68M	+11.2%
Jun 2017	$554.41M	-25.2%
Mar 2017	$740.84M	+41.6%
Dec 2016	$523.06M	-12.9%
Sep 2016	$600.68M	+27.7%
Jun 2016	$470.43M	-16.3%
Mar 2016	$562.05M	+31.6%
Dec 2015	$427.00M	+0.7%
Sep 2015	$424.22M	+22.9%
Jun 2015	$345.30M	-22.9%
Mar 2015	$448.05M	+33.1%
Dec 2014	$336.55M	-18.7%
Sep 2014	$414.18M	+36.9%
Jun 2014	$302.60M	-14.3%
Mar 2014	$352.94M	+16.2%
Dec 2013	$303.73M	+44.8%
Sep 2013	$209.70M	-7.2%
Jun 2013	$225.87M	-42.0%
Mar 2013	$389.20M	+22.0%
Dec 2012	$319.13M	-9.2%
Sep 2012	$351.41M	-2.4%
Jun 2012	$360.17M	-13.0%
Mar 2012	$413.79M	+28.3%
Dec 2011	$322.48M	+5.6%
Sep 2011	$305.33M	-12.0%
Jun 2011	$346.83M	-12.1%
Mar 2011	$394.38M	+29.1%
Dec 2010	$305.41M	+7.6%
Sep 2010	$283.93M	+0.3%

Month	Value	Change
Jun 2010	$283.18M	-15.7%
Mar 2010	$335.76M	+17.9%
Dec 2009	$284.79M	+14.0%
Sep 2009	$249.85M	+2.2%
Jun 2009	$244.56M	-10.4%
Mar 2009	$272.87M	+23.7%
Dec 2008	$220.58M	-2.0%
Sep 2008	$225.04M	+0.5%
Jun 2008	$223.89M	-15.1%
Mar 2008	$263.60M	+26.6%
Dec 2007	$208.29M	+5.4%
Sep 2007	$197.62M	-4.8%
Jun 2007	$207.69M	-14.7%
Mar 2007	$243.37M	+2.4%
Dec 2006	$237.62M	+8.8%
Sep 2006	$218.32M	+4.9%
Jun 2006	$208.13M	-2.9%
Mar 2006	$214.34M	+19.0%
Dec 2005	$180.18M	-4.9%
Sep 2005	$189.51M	+10.2%
Jun 2005	$172.05M	-17.9%
Mar 2005	$209.67M	+45.7%
Dec 2004	$143.86M	-26.0%
Sep 2004	$194.29M	-28.9%
Jun 2004	$273.10M	-2.1%
Mar 2004	$279.00M	+20.3%
Dec 2003	$232.00M	+6.4%
Sep 2003	$218.00M	-12.1%
Jun 2003	$248.00M	-4.2%
Mar 2003	$259.00M	+26.0%
Dec 2002	$205.52M	-4.2%
Sep 2002	$214.44M	+4.3%
Jun 2002	$205.63M	-2.0%
Mar 2002	$209.92M	+20.8%
Dec 2001	$173.84M	+57.4%
Sep 2001	$110.47M	+69.2%
Jun 2001	$65.30M	-5.0%
Mar 2001	$68.71M	+11.4%
Dec 2000	$61.68M	+0.8%
Sep 2000	$61.22M	+18.4%
Jun 2000	$51.69M	-6.2%
Mar 2000	$55.08M	+10.9%
Dec 1999	$49.68M	-19.9%
Sep 1999	$62.03M	+46.2%
Jun 1999	$42.44M	-8.0%
Mar 1999	$46.12M	+13.4%
Dec 1998	$40.68M	-7.2%
Sep 1998	$43.82M	+8.3%
Jun 1998	$40.46M	-4.4%
Mar 1998	$42.33M	+6.2%
Dec 1997	$39.84M	-31.8%
Sep 1997	$58.40M	+134.5%
Jun 1997	$24.90M	-30.8%
Mar 1997	$36.00M	+12.5%
Dec 1996	$32.00M	+41.6%
Sep 1996	$22.60M	-24.2%
Jun 1996	$29.80M	-0.3%
Mar 1996	$29.90M	+10.3%
Dec 1995	$27.10M	-8.4%
Sep 1995	$29.60M	+10.9%
Jun 1995	$26.70M	-3.6%
Mar 1995	$27.70M	+13.5%
Dec 1994	$24.40M	-

FAQ

What is the current quarterly EBITDA of COR?
As of today, COR quarterly EBITDA is $1.61B
What is COR quarterly EBITDA most recent change?
COR quarterly EBITDA was up +27.28% on March 31, 2026
What is 1-year change in COR quarterly EBITDA?
COR quarterly EBITDA is up +26.10% year-over-year
How far is COR quarterly EBITDA from its all-time high?
COR quarterly EBITDA is currently at its all-time high
How does COR quarterly EBITDA rank versus sector peers?
COR quarterly EBITDA is higher than 97.78% of companies in Healthcare sector
When is COR next earnings release?
The next earnings release for COR is on August 5, 2026

TTM EBITDA

$5.23B$333.40M+6.80%

March 31, 2026

Summary

Current Value: As of today, COR TTM EBITDA is $5.23B, up +6.80% on March 31, 2026
Historical Performance: COR TTM EBITDA is up +22.23% year-over-year, up +58.26% over the past 3 years
All-Time High Comparison: COR TTM EBITDA is currently at its all-time high
3-Year Low Comparison: COR TTM EBITDA is +58.26% above its 3-year low of $3.31B reached on an earlier date
Sector Comparison: COR TTM EBITDA is higher than 97.50% of companies in Healthcare sector

Performance

COR Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Mar 31, 26	$5.23B	+6.8%	+22.2%	+58.3%	+92.7%
Annual EBITDA	Sep 30, 25	$4.98B	–	+20.1%	+44.5%	+105.5%
Quarterly EBITDA	Mar 31, 26	$1.61B	+27.3%	+26.1%	+65.2%	+100.0%
Price	May 19, 26	$268.35	-25.3%	-8.3%	+54.8%	+126.0%
PE Ratio	May 19, 26	20.59	-52.3%	-39.4%	-7.6%	–
TTM Revenue	Mar 31, 26	$328.68B	+0.9%	+6.0%	+32.8%	+67.5%
TTM EPS	Mar 31, 26	$13.03	+56.8%	+51.3%	+67.6%	+170.8%
	Mar 31, 26	$4.21B	+9.0%	+32.1%	+65.0%	+82.0%
TTM Net Income	Mar 31, 26	$2.55B	+55.6%	+49.6%	+63.0%	+168.2%

TTM EBITDA Highs

COR TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$5.23B	Mar 31, 26	at high
3Y	$5.23B	Mar 31, 26	at high
5Y	$5.23B	Mar 31, 26	at high
All	$5.23B	Mar 31, 26	at high

TTM EBITDA Lows

COR TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$4.28B	N/A	+22.2%
3Y	$3.31B	N/A	+58.3%
5Y	$2.72B	N/A	+92.7%
All	$24.40M	Dec 1, 94	>+9999.0%

TTM EBITDA History

Month	Value	Change
Mar 2026	$5.23B	+6.8%
Dec 2025	$4.90B	+4.1%
Sep 2025	$4.71B	+3.6%
Jun 2025	$4.54B	+6.1%
Mar 2025	$4.28B	+3.1%
Dec 2024	$4.15B	+1.1%
Sep 2024	$4.11B	+4.1%
Jun 2024	$3.95B	+3.7%
Mar 2024	$3.81B	+4.7%
Dec 2023	$3.63B	+6.5%
Sep 2023	$3.41B	+2.0%
Jun 2023	$3.35B	+1.2%
Mar 2023	$3.31B	-1.7%
Dec 2022	$3.37B	-2.5%
Sep 2022	$3.45B	-3.1%
Jun 2022	$3.56B	-8.2%
Mar 2022	$3.88B	+6.2%
Dec 2021	$3.65B	+4.9%
Sep 2021	$3.48B	+6.2%
Jun 2021	$3.28B	+20.7%
Mar 2021	$2.72B	+4.2%
Dec 2020	$2.61B	+7.5%
Sep 2020	$2.43B	+7.4%
Jun 2020	$2.26B	-0.6%
Mar 2020	$2.27B	-2.5%
Dec 2019	$2.33B	-1.1%
Sep 2019	$2.36B	+3.3%
Jun 2019	$2.28B	+0.2%
Mar 2019	$2.27B	+5.4%
Dec 2018	$2.16B	+0.3%
Sep 2018	$2.15B	-9.7%
Jun 2018	$2.38B	+0.6%
Mar 2018	$2.37B	-4.2%
Dec 2017	$2.47B	+1.5%
Sep 2017	$2.43B	+0.7%
Jun 2017	$2.42B	+3.6%
Mar 2017	$2.34B	+8.3%
Dec 2016	$2.16B	+4.7%
Sep 2016	$2.06B	+9.4%
Jun 2016	$1.88B	+7.1%
Mar 2016	$1.76B	+6.9%
Dec 2015	$1.64B	+5.8%
Sep 2015	$1.55B	+0.7%
Jun 2015	$1.54B	+2.8%
Mar 2015	$1.50B	+6.8%
Dec 2014	$1.41B	+2.4%
Sep 2014	$1.37B	+17.5%
Jun 2014	$1.17B	+7.0%
Mar 2014	$1.09B	-3.2%
Dec 2013	$1.13B	-1.3%
Sep 2013	$1.14B	-11.0%
Jun 2013	$1.29B	-9.5%
Mar 2013	$1.42B	-1.7%
Dec 2012	$1.44B	-0.2%
Sep 2012	$1.45B	+3.3%
Jun 2012	$1.40B	+1.0%
Mar 2012	$1.39B	+1.4%
Dec 2011	$1.37B	+1.3%
Sep 2011	$1.35B	+1.6%
Jun 2011	$1.33B	+5.0%
Mar 2011	$1.27B	+4.9%
Dec 2010	$1.21B	+1.7%
Sep 2010	$1.19B	+3.0%

Month	Value	Change
Jun 2010	$1.15B	+3.5%
Mar 2010	$1.11B	+6.0%
Dec 2009	$1.05B	+6.5%
Sep 2009	$987.86M	+2.6%
Jun 2009	$963.05M	+2.2%
Mar 2009	$942.38M	+1.0%
Dec 2008	$933.11M	+1.3%
Sep 2008	$920.81M	+3.1%
Jun 2008	$893.39M	+1.8%
Mar 2008	$877.19M	+2.4%
Dec 2007	$856.96M	-3.3%
Sep 2007	$886.29M	-2.3%
Jun 2007	$906.99M	-0.0%
Mar 2007	$907.44M	+3.3%
Dec 2006	$878.41M	+7.0%
Sep 2006	$820.98M	+3.6%
Jun 2006	$792.17M	+4.8%
Mar 2006	$756.09M	+0.6%
Dec 2005	$751.42M	+5.1%
Sep 2005	$715.10M	-0.7%
Jun 2005	$719.88M	-12.3%
Mar 2005	$820.93M	-7.8%
Dec 2004	$890.25M	-9.0%
Sep 2004	$978.39M	-2.4%
Jun 2004	$1.00B	+2.6%
Mar 2004	$977.00M	+2.1%
Dec 2003	$957.00M	+2.8%
Sep 2003	$930.52M	+0.4%
Jun 2003	$926.95M	+4.8%
Mar 2003	$884.58M	+5.9%
Dec 2002	$835.50M	+3.9%
Sep 2002	$803.82M	+14.9%
Jun 2002	$699.86M	+25.1%
Mar 2002	$559.53M	+33.8%
Dec 2001	$418.32M	+36.6%
Sep 2001	$306.16M	+19.2%
Jun 2001	$256.91M	+5.6%
Mar 2001	$243.29M	+5.9%
Dec 2000	$229.67M	+5.5%
Sep 2000	$217.67M	-0.4%
Jun 2000	$218.48M	+4.4%
Mar 2000	$209.24M	+4.5%
Dec 1999	$200.27M	+4.7%
Sep 1999	$191.27M	+10.5%
Jun 1999	$173.06M	+1.2%
Mar 1999	$171.08M	+2.3%
Dec 1998	$167.29M	+0.5%
Sep 1998	$166.45M	-8.1%
Jun 1998	$181.03M	+9.4%
Mar 1998	$165.47M	+4.0%
Dec 1997	$159.14M	+5.2%
Sep 1997	$151.30M	+31.0%
Jun 1997	$115.50M	-4.1%
Mar 1997	$120.40M	+5.3%
Dec 1996	$114.30M	+4.5%
Sep 1996	$109.40M	-6.0%
Jun 1996	$116.40M	+2.7%
Mar 1996	$113.30M	+2.0%
Dec 1995	$111.10M	+2.5%
Sep 1995	$108.40M	+37.6%
Jun 1995	$78.80M	+51.2%
Mar 1995	$52.10M	+113.5%
Dec 1994	$24.40M	-

FAQ

What is the current TTM EBITDA of COR?
As of today, COR TTM EBITDA is $5.23B
What is COR TTM EBITDA most recent change?
COR TTM EBITDA was up +6.80% on March 31, 2026
What is 1-year change in COR TTM EBITDA?
COR TTM EBITDA is up +22.23% year-over-year
How far is COR TTM EBITDA from its all-time high?
COR TTM EBITDA is currently at its all-time high
How does COR TTM EBITDA rank versus sector peers?
COR TTM EBITDA is higher than 97.50% of companies in Healthcare sector
When is COR next earnings release?
The next earnings release for COR is on August 5, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

COR Official Website www.cencora.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1140859/000114085925000131/0001140859-25-000131-index.htm
COR Profile on Yahoo Finance finance.yahoo.com/quote/COR
COR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cor